Nissan North America, Inc.
Summary
NHTSA campaign 21V474: Nissan North America, Inc. recalled for a safety defect. An insecurely anchored child seat can move during a sudden stop or crash, increasing the risk of injury.
Details
Source
nhtsa
External ID
21V474
Action Date
2021-06-25
Status
Ongoing
Category
vehicle
Product Description
Nissan North America, Inc. (Nissan) is recalling certain 2021 Rogue vehicles. The second-row upper tether wires may have been improperly welded to the seatback frame, preventing a child seat from being securely anchored. As such, these vehicles fail to comply with the requirements of Federal Motor Vehicle Safety Standard number 225, "Child Restraint Anchorage Systems."
Company
Context & Analysis
Nissan North America, Inc. has 85 FDA actions in our database.
Frequently Asked Questions
How often does Nissan North America, Inc. have FDA actions?
Nissan North America, Inc. has 85 FDA actions in our database, including 0 recalls and 0 device clearances.
Where can I find the official FDA record?
The official record is available on FDA.gov. Use the link above to view the complete official filing. You can also use the openFDA API to query this record programmatically.
Want to know the moment something like this happens?
Get alerts for vehicle